ArticleYonsei medical journal2025
Prediction Model for Insulin Resistance and Implications for MASLD in Youth: A Novel Marker, the Pediatric Insulin Resistance Assessment Score.
Article in Yonsei medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07731360 (A Non-Invasive Diagnostic Panel for MASLD in Children With Obesity), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Non-Invasive Diagnostic Panel for MASLD in Children With Obesity: Evaluation of a Multiparametric Biomarker Panel and Genetic Risk Score Using LASSO-Regularized Logistic Regression - The PedMASLD-MultiOmics Pilot Study
Who cites it
2 citing papers in PubMed.
- Article
- Current status survey and risk factor analysis of metabolic dysfunction-associated steatotic liver disease among adolescents in Hainan Province.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeInsulin resistance (IR) is a condition closely associated with cardiovascular risk factors and metabolic dysfunction-associated steatotic liver disease (MASLD) is emerging as a significant IR-related complication. We aimed to develop a predictive model for IR in youths and implicate this model for MASLD. MATERIALS AND
methodsA total of 1588 youths from the population-based data were included in the training set. For the test sets, 121 participants were included for IR and 50 for MASLD from real-world clinic data. Logistic regression analysis, random forest, extreme gradient boosting (XGBoost), light gradient boosting machine (GBM), and deep neural network (DNN) were used to develop the models. A nomogram scoring system was constructed based on a model used to predict the probability of IR and MASLD.
resultsAfter stepwise selection, age, body mass index (BMI) standard deviation score (SDS), waist circumference (WC), systolic blood pressure, HbA1c, high-density lipoprotein cholesterol, triglyceride, and alanine aminotransferase levels were included in the model. A nomogram scoring system was constructed based on a multivariable logistic regression model. The areas under the curves (AUCs) of the models for IR prediction in external validation were 0.75 (logistic regression), 0.78 (random forest), 0.72 (XGBoost), 0.71 (light GBM), and 0.71 (DNN). For MASLD prediction, the AUCs were 0.93 (logistic regression), 0.95 (random forest), 0.90 (XGBoost), 0.91 (light GBM), and 0.85 (DNN). BMI SDS and WC SDS were the most important contributors to IR prediction in all models.
conclusionThe Pediatric Insulin Resistance Assessment Score is a novel scoring system for predicting IR and MASLD in youths.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.